[go: up one dir, main page]

YU47044B - Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase - Google Patents

Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase

Info

Publication number
YU47044B
YU47044B YU40687A YU40687A YU47044B YU 47044 B YU47044 B YU 47044B YU 40687 A YU40687 A YU 40687A YU 40687 A YU40687 A YU 40687A YU 47044 B YU47044 B YU 47044B
Authority
YU
Yugoslavia
Prior art keywords
weight
methylcellulose
tablets
prolonged
procedure
Prior art date
Application number
YU40687A
Other languages
English (en)
Other versions
YU40687A (en
Inventor
M. Mohar
Lj. Kremžar
Z. Jerala-Štrukelj
J. Urbančič-Smerkolj
A. Lenardić
P. Cvelbar
F. Lahgros
V. Nikolić
M. Lampert
M. Mavec
M. Žorž
Z. Kopitar
Original Assignee
LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. filed Critical LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o.
Priority to YU40687A priority Critical patent/YU47044B/sh
Priority to SI8710406A priority patent/SI8710406B/sl
Priority to EP19880103715 priority patent/EP0284849B1/en
Priority to DE19883882765 priority patent/DE3882765T2/de
Priority to JP63056487A priority patent/JPH0757726B2/ja
Publication of YU40687A publication Critical patent/YU40687A/xx
Publication of YU47044B publication Critical patent/YU47044B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

POSTUPAK ZA DOBIJANJE TABLETA SA PRODUŽENIM DELOVANJEM NA BAZI HIDROKSIPROPIL-METILCELULOZE VELIKE MOLEKULARNE MASE, koje sadrže terapeutski aktivnu lekovitu komponentu i nosač, naznačen time, što se presuje i oblikuje smeša terapeutski aktivne lekovite omponente i nosača koji se sastoji od hidroksipropilmetil-celuloze, sa sadržajem metoksila od 28 do 309 mas.%, hidroksipropoksila od 7,5 do 12 mas.% i prosečnom molskom masom od najmanje 50.000, u količini od oko 20 do oko 40 mas.% tablete, u datom slučaju 10 mas% glicerol ditripalmitostearata i od oko 10 do oko 20 mas% mikrokristalne celuloze i drugih uobičajenih farmaceutski prihvatljivih pomoćnih materija.- Prijava sadrži još 1 zavisan zahtev.
YU40687A 1987-03-11 1987-03-11 Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase YU47044B (sh)

Priority Applications (5)

Application Number Priority Date Filing Date Title
YU40687A YU47044B (sh) 1987-03-11 1987-03-11 Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
SI8710406A SI8710406B (sl) 1987-03-11 1987-03-11 Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
EP19880103715 EP0284849B1 (en) 1987-03-11 1988-03-09 Sustained release tablets on the basis of high molecular weight hydroxypropylmethylcellulose and a process for their manufacture
DE19883882765 DE3882765T2 (de) 1987-03-11 1988-03-09 Tabletten mit verzögerter Freisetzung auf der Basis von hochmolekularer Hydroxypropylmethylcellulose und Verfahren zu ihrer Herstellung.
JP63056487A JPH0757726B2 (ja) 1987-03-11 1988-03-11 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU40687A YU47044B (sh) 1987-03-11 1987-03-11 Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase

Publications (2)

Publication Number Publication Date
YU40687A YU40687A (en) 1991-02-28
YU47044B true YU47044B (sh) 1994-12-28

Family

ID=25549781

Family Applications (1)

Application Number Title Priority Date Filing Date
YU40687A YU47044B (sh) 1987-03-11 1987-03-11 Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase

Country Status (5)

Country Link
EP (1) EP0284849B1 (sh)
JP (1) JPH0757726B2 (sh)
DE (1) DE3882765T2 (sh)
SI (1) SI8710406B (sh)
YU (1) YU47044B (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
ID20270A (id) * 1997-05-18 1998-11-19 Adel Abdel Wadood Gomaa Prof D Preparat topikal yang baru untuk pengobatan ketidak-fungsian penis
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US5851555A (en) * 1997-08-15 1998-12-22 Fuisz Technologies Ltd. Controlled release dosage forms containing water soluble drugs
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
DE60017938T2 (de) * 1999-12-03 2006-01-12 Polichem S.A. Arzneizusammensetzungen und herstellungsverfahren von ergotalkaloidhaltigen arzneizusammensetzungen mit verzögerter wirkstoffabgabe und verbesserter bioverfügbarkeit
WO2003103634A1 (en) * 2002-06-07 2003-12-18 Ranbaxy Laboratories Limited Sustained release oral dosage forms of gabapentin
US20060039974A1 (en) * 2002-09-11 2006-02-23 Takeda Pharmaceutical Company Limited Sustained release preparation
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
EP1781261A1 (en) * 2004-06-17 2007-05-09 Forest Laboratories, Inc. Modified release formulation of memantine
EP2070520A1 (en) 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
WO2011099573A1 (ja) * 2010-02-12 2011-08-18 大正製薬株式会社 徐放性製剤
CN113521024A (zh) * 2017-04-17 2021-10-22 上海葆隆生物科技有限公司 一种碳酸锂缓释片

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
US4734285A (en) * 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions

Also Published As

Publication number Publication date
DE3882765D1 (de) 1993-09-09
SI8710406B (sl) 1998-08-31
SI8710406A (en) 1996-08-31
YU40687A (en) 1991-02-28
JPH0757726B2 (ja) 1995-06-21
DE3882765T2 (de) 1994-03-10
JPS63290818A (ja) 1988-11-28
EP0284849B1 (en) 1993-08-04
EP0284849A1 (en) 1988-10-05

Similar Documents

Publication Publication Date Title
YU47044B (sh) Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
DE69838300D1 (de) Pharmazeutische suspensionstabletten-zusammenstellungen
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
SE8207167D0 (sv) Metod for framstellning av terapeutiska foreningar med forlengd utlosningstid baserade pa hydroxypropylmetylcellulosa
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
SE8304393L (sv) Naproxen- och naproxennatriumtabletter av controlled release-typ
SE8301579D0 (sv) Metod for preparering av terapeutiska foreningar med vidmakthallande utlosning, baserade pa hydroxypropylmetylcellulosa med hog molekyler vikt
NO20083842L (no) Anvendelse av opploselig lymfotoksin-beta-reseptor for fremstilling av medikamenter
ES2006394A6 (es) Un sistema bilaminado para liberar un farmaco beneficioso a un medio de uso.
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
EP0525389A3 (en) Process for preparing mechanically stable, well disintegrating tablets from small active agent containing solid forms
DE69816951D1 (de) Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix
HUT50631A (en) Process for producing long-acting pharmaceutical compositions comprising etodolac active ingredient
MY104010A (en) Pharmaceutical compositions.
CL2004001182A1 (es) Composicion farmaceutica que comprende a una microparticula de liberacion sostenida la que contiene a un derivado de 1,2 benzazol; procedimiento de preparacion de la microparticula; util como broncodilatador, antipsicoticos y en otros problemas del s
DE2964530D1 (en) 2,3,4,5-tetrahydro-1h-3-benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
RU2002123182A (ru) Содержащая ибупрофен композиция
BE1002788A3 (fr) Composition pharmaceutique contenant un extrait vegetal et procede pour sa preparation.
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
NO178338C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse samt mellomprodukt
PL360972A1 (en) Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole
JPS5344617A (en) Drug composition
ES291570A1 (es) Procedimiento para la preparacion de nuevos medicamentos solidos
HUP9902681A2 (hu) Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény